Sfoglia per AUTORE
NADA E
Collezione ASL Torino 5

  

Items : 15

Diabetic retinopathy screening with confocal fundus camera and artificial intelligence - assisted grading. in European journal of ophthalmology / Eur J Ophthalmol. 2025 Mar;35(2):679-688. doi: 10.1177/11206721241272229. Epub 2024 Aug 7.

2025
ASL Torino 5

Piatti A; Rui C; Gazzina S; Tartaglino B; Romeo F; Manti R; Doglio M; Nada E; Giorda CB;

Feasibility and accuracy of the screening for diabetic retinopathy using a fundus camera and an artificial intelligence pre-evaluation application. in Acta diabetologica / Acta Diabetol. 2024 Jan;61(1):63-68. doi: 10.1007/s00592-023-02172-2. Epub 2023 Sep 7.

2024
ASL Torino 5

Piatti A; Romeo F; Manti R; Doglio M; Tartaglino B; Nada E; Giorda CB;

Hospitalisation for herpes zoster in people with and without diabetes: A 10-year-observational study. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2024 Apr;210:111603. doi: 10.1016/j.diabres.2024.111603. Epub 2024 Mar 8.

2024
ASL Città di Torino
ASL Torino 3
ASL Torino 5

Costa G; Romeo F; Nada E; Picariello R; Tartaglino B; Giorda CB; Gnavi R;

Hepatocellular carcinoma in a large cohort of type 2 diabetes patients. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2023 Jun;200:110684. doi: 10.1016/j.diabres.2023.110684. Epub 2023 Apr 24.

2023
ASL Città di Torino
ASL Torino 3
ASL Torino 5

Gnavi R; Monge L; Manti R; Nada E; Costa G; Tartaglino B; Picariello R; Giorda CB;

Instructive lessons from the analysis of assistance in diabetes during the first phase of COVID-19 pandemic. in Acta diabetologica / Acta Diabetol. 2022 Jun;59(6):861-864. doi: 10.1007/s00592-022-01855-6. Epub 2022 Feb 19.

2022
ASL Città di Torino
ASL Torino 3
ASL Torino 5

Romeo F; Doglio M; Nada E; Tartaglino B; Landriscina T; Picariello R; Giorda CB; Gnavi R;

Hepatic fibrosis of any origin in a large population of type 2 diabetes patients. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2021 Sep 22;31(10):2887-2894. doi: 10.1016/j.numecd.2021.06.020. Epub 202

2021
ASL Città di Torino
ASL Torino 3
ASL Torino 5

Costa G; Romeo F; Linzalata C; Nada E; Picariello R; Tartaglino B; Gnavi R; Giorda CB;

From swab testing to health outcomes within the T2DM population: Impact of diabetes background on COVID19 progression. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2021 Oct;180:109021. doi: 10.1016/j.diabres.2021.109021. Epub 2021 Aug 23.

2021
ASL Città di Torino
ASL Torino 3
ASL Torino 5

Gnavi R; Romeo F; Costa G; Doglio M; Nada E; Picariello R; Tartaglino B; Giorda CB;

Results of the Adequacy of glycemiC Control in pAtients with type 2 Diabetes mEllitus treated with Metformin monotherapY at the maximal-tolerated dose (ACCADEMY) study. in Endocrine / Endocrine. 2016 Jun;52(3):507-15. doi: 10.1007/s12020-015-0692-9. Epub 2015 Aug 15.

2016
ASL Torino 5

Giorda CB; Cercone S; Nada E;

Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies. in Endocrine / Endocrine. 2015 Mar;48(2):461-71. doi: 10.1007/s12020-014-0386-8. Epub 2014 Aug 22.

2015
ASL Torino 5

Giorda CB; Sacerdote C; Nada E; Marafetti L; Baldi I; Gnavi R;

A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position. in Diabetes, obesity & metabolism / Diabetes Obes Metab. 2014 Nov;16(11):1041-7. doi: 10.1111/dom.12297. Epub 2014 Apr 29.

2014
ASL Torino 5

Giorda CB; Nada E; Tartaglino B; Marafetti L; Gnavi R;

Comparison of direct costs of type 2 diabetes care: different care models with different outcomes. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2014 Jul;24(7):717-24. doi: 10.1016/j.numecd.2014.01.009. Epub 2014 Jan 2

2014
ASL Torino 3
ASL Torino 5

Costa G; Marafetti L; Tartaglino B; Picariello R; Nada E; Giorda CB; Petrelli A; Gnavi R;

Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study. in The lancet. Diabetes & endocrinology / Lancet Diabetes Endocrinol. 2014 Feb;2(2):111-5. doi: 10.1016/S2213-8587(13)70147-5. Epub 2013 Nov 1

2014
ASL Torino 3
ASL Torino 5

Costa G; Marafetti L; Tartaglino B; Nada E; Picariello R; Giorda CB; Gnavi R;

Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature. in Endocrine / Endocrine. 2014 Aug;46(3):406-19. doi: 10.1007/s12020-014-0179-0. Epub 2014 Feb 8.

2014
ASL Torino 5

Giorda CB; Nada E; Tartaglino B;

Erratum to: Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature (Endocrine DOI: 10.1007/s12020-014-0179-0) in Endocrine

2014
ASL Torino 5

Giorda CB; Nada E; Tartaglino B;

The impact of adherence to screening guidelines and of diabetes clinics referral on morbidity and mortality in diabetes. in PloS one / PLoS One. 2012;7(4):e33839. doi: 10.1371/journal.pone.0033839. Epub 2012 Apr 3.

2012
ASL Torino 5

Giorda C; Picariello R; Nada E; Tartaglino B; Marafetti L; Costa G; Gnavi R;